CPS Faculty Publish New Research on AI Regulation in Global Drug Development
Faculty members from Northeastern University’s College of Professional Studies (CPS) have recently published new research in Frontiers in Drug Safety and Regulation, contributing to global conversations about how artificial intelligence (AI) is shaping the future of healthcare innovation. The article explores the growing complexity of regulating AI-enabled therapies, an issue that has gained urgency as new technologies transform drug discovery, clinical trials, and patient safety practices worldwide.
The research introduces an AI-powered regulatory intelligence system designed to monitor and compare drug-related AI regulations across major global authorities, including those in the United States, Europe, and international organizations. By analyzing hundreds of thousands of regulatory documents published in recent years, the system helps identify patterns, gaps, and opportunities for greater alignment across jurisdictions. This approach aims to support policymakers, regulators, and pharmaceutical innovators as they navigate an increasingly fragmented regulatory landscape.
Ultimately, the work highlights the potential for data-driven tools to foster more transparent, collaborative, and equitable access to emerging therapies around the world. As AI continues to reshape healthcare, research like this underscores CPS faculty’s commitment to advancing practical, workforce-relevant innovation that bridges academic insight with real-world impact.
Read Full Article: https://www.frontiersin.org/journals/drug-safety-and-regulation/articles/10.3389/fdsfr.2026.1718379/full
